Approximately 15% of individuals diagnosed with cancer have familial cancer syndromes. In familial cancers, both the treatment algorithms and the preventative measures needed to protect the individual from developing new cancers differ from those used in sporadic cases. Other members of the family are also at increased risk in familial cancer scenarios. For this reason, identifying a familial cancer diagnosis is of great importance—not only to guide treatment but also to help protect other at-risk relatives.
All individuals who have been diagnosed with cancer—whether they are currently undergoing active treatment or have had cancer in the past—should undergo this genetic testing. Additionally, individuals with a family history of cancer should also consider taking this test in order to assess and reduce their own cancer risk.
Test to Be Performed
-
Whole Exome Sequencing (WES)
Who Can Take the Test?
-
The general population
-
Especially individuals who have had cancer themselves or have a family history of cancer
Number of Genes Analyzed
-
257
Assessments Based on Gene Analysis
-
Broader familial cancer risk assessment
-
Identification of hereditary cancers that may influence treatment planning
